Global Edible Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Edible Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Edible Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Edible Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Medical Care and Livestock are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Edible Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Edible Vaccine key companies include GSK, Sanofi, Merck, Merial, Santa Cruz Animal Health and Ceva, etc. GSK, Sanofi, Merck are top 3 players and held % share in total in 2022.
Edible Vaccine can be divided into Inactivated Vaccines and Others, etc. Inactivated Vaccines is the mainstream product in the market, accounting for % share globally in 2022.
Edible Vaccine is widely used in various fields, such as Medical Care, Livestock and Others,, etc. Medical Care provides greatest supports to the Edible Vaccine industry development. In 2022, global % share of Edible Vaccine went into Medical Care filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Edible Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
GSK
Sanofi
Merck
Merial
Santa Cruz Animal Health
Ceva
Segment by Type
Inactivated Vaccines
Others
Medical Care
Livestock
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Edible Vaccine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Edible Vaccine introduction, etc. Edible Vaccine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Edible Vaccine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Edible Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Edible Vaccine key companies include GSK, Sanofi, Merck, Merial, Santa Cruz Animal Health and Ceva, etc. GSK, Sanofi, Merck are top 3 players and held % share in total in 2022.
Edible Vaccine can be divided into Inactivated Vaccines and Others, etc. Inactivated Vaccines is the mainstream product in the market, accounting for % share globally in 2022.
Edible Vaccine is widely used in various fields, such as Medical Care, Livestock and Others,, etc. Medical Care provides greatest supports to the Edible Vaccine industry development. In 2022, global % share of Edible Vaccine went into Medical Care filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Edible Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
GSK
Sanofi
Merck
Merial
Santa Cruz Animal Health
Ceva
Segment by Type
Inactivated Vaccines
Others
Segment by Application
Medical Care
Livestock
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Edible Vaccine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Edible Vaccine introduction, etc. Edible Vaccine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Edible Vaccine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.